71 filings
Page 2 of 4
8-K
3q4u534bayp yy
8 Nov 22
Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones
4:31pm
8-K
hbh5hmj8
24 Oct 22
Departure of Directors or Certain Officers
7:00am
8-K
05d2ag7
8 Aug 22
Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated Milestones
4:32pm
8-K
bhr06hosqtv1z
26 Jul 22
Other Events
4:02pm
8-K
at8ougm9jg28o fo0b
27 Jun 22
Entry into a Material Definitive Agreement
7:31pm
8-K
tbwr0fy1pj lt
16 Jun 22
Other Events
7:00am
8-K
r4l4z3gd4 lc72
7 Jun 22
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
hchlj
9 May 22
Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones
4:31pm
8-K
0200sg ch
20 Apr 22
Entry into a Material Definitive Agreement
7:00am
8-K
bl1hu6 9oaen2wf
28 Feb 22
Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones
4:36pm
8-K
19h0w0iwqig9t9n7
10 Jan 22
Regulation FD Disclosure
7:01am
8-K
egk0fawe
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
u1pyh13y23 byfk0
27 Dec 21
Entry into a Material Definitive Agreement
7:00am
8-K
f9yxc518j
17 Nov 21
Departure of Directors or Certain Officers
7:00am
8-K
eqqktqi286r
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
8-K
92nmv
12 Oct 21
Entry into a Material Definitive Agreement
7:00am
8-K
6nqmtgr44i41tz0
30 Sep 21
Other Events
7:00am
8-K
001xl17wji57l
9 Aug 21
Business Highlights and Anticipated Second Half 2021 Milestones
7:01am
8-K
3ukk3cg
17 Jun 21
Entry into a Material Definitive Agreement
5:29pm
8-K
g1d1av
4 Jun 21
Submission of Matters to a Vote of Security Holders
7:00am